Here are details, filed by REVO in 2009, showing that the company made an exempt placement in 2009.
The Company currently has another Private Placement Memorandum open for 250,000 shares at $1.25 dated April 21, 2009.
NOTE 12 – SUBSEQUENT EVENTS The company closed the private placement on November 10, 2009.
This private placement was supported by representations to prospective investors that having acquired patents (in 2007) and developed its marketing plans it was now about to launch its product. The 10Q stated:
Sales Strategy We are working with Virsalent to help us identify companies that may have immediate uses for our technology. While we have not yet done so, we expect to enter into an engagement agreement with Virsalent in the near future. Virsalent, is a California corporation that has expertise in marketing and sales Our discussions with Virsalent revolve around the development and execution of the sales and marketing plan for the EYETALK system to the public.
Investors were told that the $1.25 private placement was to fund a product launch to the public in 2009/20010. It's now 2013, and nothing has been produced or sold.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.